CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −4,375 | $17.37 | $76K | 122,672 |
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +9,375 | $2.65 | $25K | 132,047 |
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −9,375 | $17.74 | $166K | 122,672 |
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +1,875 | $7.20 | $14K | 124,547 |
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −1,875 | $17.74 | $33K | 122,672 |
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −4,375 | 65,625 | ||
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −9,375 | 15,000 | ||
| 2019-04-08 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −1,875 | 98,125 | ||
| 2019-03-11 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −10,000 | $20.02 | $200K | 122,249 |
| 2019-02-28 | GILMAN STEVEN C Director | Option exercise | +7,500 | $2.76 | $21K | 7,500 |
| 2019-02-28 | GILMAN STEVEN C Director | Sale | −7,500 | $18.02 | $135K | 0 |
| 2019-02-28 | GILMAN STEVEN C Director | Option exercise · Stock Option (right to buy) | −7,500 | 7,500 | ||
| 2019-02-15 | Colangelo Dominick President and CEO | Option exercise | +27,500 | $3.02 | $83K | 102,663 |
| 2019-02-15 | Colangelo Dominick President and CEO | Option exercise | +8,692 | $1.95 | $17K | 111,355 |
| 2019-02-15 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −27,500 | 383,452 | ||
| 2019-02-15 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −8,692 | 63,496 | ||
| 2019-02-11 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −10,000 | $17.09 | $171K | 132,249 |
| 2019-02-06 | Orlando Daniel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +130,697 | 130,697 | ||
| 2019-02-06 | Orlando Daniel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +9,303 | 9,303 | ||
| 2019-02-06 | Orlando Daniel Chief Operating Officer | Grant or award · Restricted Stock Unit | +14,000 | 14,000 |
Page 60 of 75 · 1,497 trades